All Par articles
-
Business
Endo to buy Par as generics consolidation continues
$8bn deal follows trend as drugmakers aim for economies of scale
-
BusinessGenerics give injectables a shot
A rash of recent acquisitions sees generics companies eager to enter speciality manufacturing market